Injection-related complications such as infectious endophthalmitis, retinal detachment, and traumatic cataract may occur with a frequency of about 0.15% after intravitreal injections of bevacizumab or triamcinolone, independently of the drug injected, according to a study published in the February issue of Eye.
Injection-related complications such as infectious endophthalmitis, retinal detachment, and traumatic cataract may occur with a frequency of about 0.15% after intravitreal injections of bevacizumab or triamcinolone, independently of the drug injected, according to a study published in the February issue of Eye.
Dr. Jost Jonas and colleagues at the Medical Faculty Mannheim of the Ruprecht-Karls-University, Germany evaluated the rate of complications after intravitreal injection of bevacizumab and triamcinolone by studying 5403 intravitreal injections of about 20 mg triamcinolone acetonide (n=1588) or 1.5 mg bevacizumab (n=3818) consecutively performed in the period from 2000 to 2007 by three surgeons for treatment of various intraocular oedematous or neovascular diseases. Follow-up after each injection was at least four weeks.
An infectious endophthalmitis necessitating pars plana vitrectomy was detected in two eyes (0.04%) from the bevacizumab group. Two eyes (0.04%) from the bevacizumab group showed a painless vitreous clouding, which subsided after intensified topical antibiotic therapy; one eye (0.02%) developed a retinal detachment; and three eyes (0.06%) (two from the bevacizumab group) showed a rapidly progressive cataract. The total rate of these complications was 8/5403 (0.15%), which was independent of the surgeon (p=0.18), the drug injected (p=0.45), and the age of the patients (p=0.87).
Thus the study authors concluded that injection-related complications may occur with a frequency of about 0.15% after intravitreal injections of bevacizumab or triamcinolone, independently of the drug injected.
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
2 Commerce Drive
Cranbury, NJ 08512